Advertisement
Advertisement
Trending on Dermatology Times
1
Celldex Advances Barzolvolimab into Phase 3 for Cold Urticaria and Symptomatic Dermographism
2
Meta-analysis Confirms Benefits of Roflumilast 0.3% Cream for PsO
3
Transparency Gaps in Prior Authorization Denials and Their Impact on Dermatologic Care
4
DeepSeek-R1 Outperforms ChatGPT-4o in Urticaria Clinical Queries
5
